Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study

Mostrar otras versiones (1)

BACKGROUND: There is an urgent need for accurate, rapid, inexpensive biomarkers that can differentiate coronavirus disease 2019 (COVID-19) from bacterial pneumonia. We assess the role of the ferritin-to-procalcitonin (F/P) ratio to classify pneumonia cases into those due to COVID-19 vs those due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharamti, Amal A, Mei, Fei, Jankousky, Katherine C, Huang, Jin, Hyson, Peter, Chastain, Daniel B, Fan, Jiawei, Osae, Sharmon, Zhang, Wayne W, Montoya, José G, Erlandson, Kristine M, Scherger, Sias J, Franco-Paredes, Carlos, Henao-Martínez, Andrés F, Shapiro, Leland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989180/
https://www.ncbi.nlm.nih.gov/pubmed/34183978
http://dx.doi.org/10.1093/ofid/ofab124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989180/
https://www.ncbi.nlm.nih.gov/pubmed/34183978
http://dx.doi.org/10.1093/ofid/ofab124

Ejemplares similares